Use of moxonidine for postmyocardial infarction treatment

摘要

A method of treating myocardial damage secondary to myocardial infarction using moxonidine or a physiologically compatible salt thereof is described. Also disclosed are pharmaceutical preparations containing moxonidine and its physiologically compatible acid addition salts that are suitable for use in acute myocardial infarction and/or post myocardial infarction management. In addition to a beneficial influence, promoting recovery and/or rehabilitation, on the myocardial status following myocardial infarction, moxonidine and its physiologically compatible acid addition salts, especially when used in the management of post myocardial infarction patients in the chronic stage, also show a preventive effect against the progression of heart failure after myocardial infarction.